Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery-Reference-Cited by-同舟云学术

Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery

Published:2016-03-08 Issue:3 Volume:57 Page:971
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Occhiutto Marcelo L.¹,Freitas Fatima R.²,Lima Patrícia P.³,Maranhão Raul C.⁴,Costa Vital P.¹

Affiliation:

1. Department of Ophthalmology University of Campinas, Campinas, Brazil

2. Heart Institute, Medical School Hospital, University of São Paulo, São Paulo, Brazil

3. Division of Anatomic Pathology, Medical School Hospital, University of São Paulo, São Paulo, Brazil

4. Heart Institute, Medical School Hospital, University of São Paulo, São Paulo, Brazil 4Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraoperative paclitaxel associated with lipid nanoparticles in trabeculectomy;Clinical & Experimental Ophthalmology;2023-06-04

2. Nanotechnology for surgical glaucoma treatment;Nanotechnology in Ophthalmology;2023

3. Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review;Experimental Eye Research;2022-04

4. Lipid Nanoparticles for the Posterior Eye Segment;Pharmaceutics;2021-12-31

5. Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems;Pharmaceuticals;2021-08-24